IGI Logo

Cipla is currently trading at Rs. 878.80, up by 6.60 points or 0.76% from its previous closing of Rs. 872.20 on the BSE.

The scrip opened at Rs. 876.90 and has touched a high and low of Rs. 883.55 and Rs. 872.90 respectively. So far 36269 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1185.20 on 01-Nov-2022 and a 52 week low of Rs. 853.50 on 14-Mar-2023.

Last one week high and low of the scrip stood at Rs. 896.85 and Rs. 853.50 respectively. The current market cap of the company is Rs. 70947.95 crore.

The promoters holding in the company stood at 33.61%, while Institutions and Non-Institutions held 49.47% and 16.91% respectively.

Cipla and its wholly owned subsidiaries -- Cipla (EU), UK and Meditab Holdings, Mauritius, have entered into a Share Purchase agreement with Africa Capitalworks SSA 3 on March 14, 2023 for sale of 51.18% stake held in Cipla Quality Chemical Industries (CQCIL), Uganda. Subsequent to the sale, CQCIL will cease to be a subsidiary of the Company. The proposed sale is expected to be completed by May 31, 2023.

The consideration to be received by Cipla (EU) and Meditab Holdings shall be in the range of $25-30 million which shall be subject to annualized audited EBITDA of CQCIL for FY23 and other adjustments as agreed between the parties and stated in the Share Purchase Agreement.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.